Société Verona Pharma Plc London S.E.
Actions
GB00B06GSH43
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- GBX | - |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 59 | 01/02/20 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 01/03/20 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/23 |
Tara Rheault
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/01/19 |
Kathleen Rickard
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/02/19 |
Victoria Stewart
IRC | Investor Relations Contact | - | 01/02/19 |
Corporate Officer/Principal | - | 01/06/20 | |
Ostra Jewell
HRO | Human Resources Officer | - | 01/09/22 |
Caroline Diaz
LAW | General Counsel | - | 01/10/21 |
Matthew Casbon
SAM | Sales & Marketing | - | 24/08/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 17/06/16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 12/09/16 |
David Ebsworth
CHM | Chairman | 69 | 01/12/14 |
Director/Board Member | 71 | 10/09/15 | |
Martin Edwards
BRD | Director/Board Member | 68 | 01/04/19 |
Sven Ullman
BRD | Director/Board Member | 68 | 10/09/15 |
Chief Executive Officer | 59 | 01/02/20 | |
Director/Board Member | 59 | 01/09/23 | |
Lisa Deschamps
BRD | Director/Board Member | 52 | 01/03/21 |
James Brady
BRD | Director/Board Member | 61 | 14/03/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 608 138 246 | 458 671 402 ( 75,42 %) | 0 | 75,42 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31 % | 103 Md | |
+0,56 % | 95,28 Md | |
+1,69 % | 22,15 Md | |
-17,37 % | 21,02 Md | |
-9,30 % | 18,15 Md | |
-41,01 % | 16,73 Md | |
-14,85 % | 16,05 Md | |
+3,21 % | 13,68 Md | |
+33,54 % | 12,17 Md |
- Bourse
- Actions
- Action VRNA
- Action
- Société Verona Pharma Plc